SCHEMBL20101017

SCHEMBL20101017

NNc1nc2cc(N3CCOCC3)ncc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
GAA P10253 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
WNT3A P56704 1/20 0.42
MAPT P10636 7/20 0.40
ALDH1A1 P00352 4/20 0.40
IDO1 P14902 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.39
TP53 P04637 3/20 0.39
PKM P14618 2/20 0.39
USP2 O75604 1/20 0.39
ALOX15 P16050 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20101049 0.81 SMN1; SMN2 (0.59) NPC1RAB9AGAAMAPTALDH1A1
SCHEMBL20101093 0.69 IDO1 (0.58) NPC1RAB9AGAAMEN1KMT2A
SCHEMBL24330005 0.66 RAB9A (0.58) NPC1RAB9AGAAMAPTALDH1A1
SCHEMBL29745217 0.66 ALDH1A1 (0.48) GAAMEN1KMT2AMAPTALDH1A1
SCHEMBL15543262 0.66 ALDH1A1 (0.48) GAAMEN1KMT2AMAPTALDH1A1
SCHEMBL1597538 0.65 PIK3CB (0.58) NPC1RAB9AGAAMEN1KMT2A
SCHEMBL21056445 0.65 NPC1 (1.00) NPC1RAB9AGAAMEN1KMT2A
SCHEMBL14162063 0.65 LRRK2 (0.49) NPC1GAAALDH1A1SMN1; SMN2HPGD
SCHEMBL23247804 0.65 SMN1; SMN2 (0.44) GAAMEN1KMT2AMAPTALDH1A1
SCHEMBL31056996 0.65 ALDH1A1 (0.44) GAAKMT2AMAPTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed